DOI . ORG {}

Matching Content Categories {📚}

• Health & Fitness
• Education
• Insurance

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🏙️ Massive Traffic: 50M - 100M visitors per month


Based on our best estimate, this website will receive around 98,426,998 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We see no obvious way the site makes money.

Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Doi.org might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

cancer, breast, google, scholar, evaluation, serum, tumor, article, markers, patients, director, hospital, research, iwase, kobayashi, itoh, marker, privacy, cookies, treatment, advanced, nagoya, city, content, information, journal, publish, search, recurrent, cea, clinical, access, surg, data, change, log, masaoka, bca, discover, tumour, jpn, carcinoma, download, national, springer, optional, analysis, personal, parties, policy,

Topics {✒️}

serum tumor markers month download article/chapter breast cancer research tumour marker courses serum markers recurrent breast cancer privacy choices/manage cookies breast cancer treatments primary breast cancer metastasising breast cancer tumor markers toyokawa city hospital serum tumor marker circulating ca15-3 levels postoperative cea time breast cancer treatment serological evaluation toyota memorial hospital prognostic factors director hiroshi itoh breast cancer patients full article pdf director tetsuo hotta director kazuo shibata director hironori tanaka director katsumi nakamae european economic area sialyl-sugar residue bca225 concentrations conditions privacy policy tumor marker concentration monoclonal antibody reactive breast cancer breast cancer 7 director shoji karamatsu director koji matsuo accepting optional cookies check access instant access predictive journal finder publish cancer res 75 breast carcinoma cancer treatment cancer patient gastrointestinal cancer serum positivity related subjects tumour shunzo kobayashi

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Evaluation of serum tumor markers in patients with advanced or recurrent breast cancer
         description:Serum CA15-3, CEA, and BCA225 concentrations were determined in 98 patients with advanced or recurrent breast cancer in an attempt to correlate elevation with clinical status. The rate of serum positivity was 68.4% (67/98), 55.1% (54/98), and 43.9% (43/98) for CA15-3, CEA, and BCA225, respectively. After a 4 weeksinterval, a 20% change of tumor marker concentration from the preceding assay correlated significantly with clinical findings. Significant elevation was predictive of new recurrence or tumor regrowth after complete remission, especially in patients with bone metastasis. The 20% change in concentration at 4 weeks was also useful in patients with tumor marker concentrations persistently beneath the cut-off level for positive. Serological evaluation of tumor markers in patients with advanced or recurrent breast cancer should seek to document 20% changes over a 4 week interval.
         datePublished:
         dateModified:
         pageStart:83
         pageEnd:88
         sameAs:https://doi.org/10.1007/BF00666074
         keywords:
            breast cancer
            CA15-3
            CEA
            BCA225
            serological evaluation
            serum markers
            Oncology
         image:
         isPartOf:
            name:Breast Cancer Research and Treatment
            issn:
               1573-7217
               0167-6806
            volumeNumber:33
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Kluwer Academic Publishers
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Hirotaka Iwase
               affiliation:
                     name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
                     address:
                        name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Shunzo Kobayashi
               affiliation:
                     name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
                     address:
                        name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yukashi Itoh
               affiliation:
                     name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
                     address:
                        name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hideki Fukuoka
               affiliation:
                     name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
                     address:
                        name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Tatsuya Kuzushima
               affiliation:
                     name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
                     address:
                        name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hiroji Iwata
               affiliation:
                     name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
                     address:
                        name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Toshinari Yamashita
               affiliation:
                     name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
                     address:
                        name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Akihiro Naitoh
               affiliation:
                     name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
                     address:
                        name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kazuko Itoh
               affiliation:
                     name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
                     address:
                        name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Akira Masaoka
               affiliation:
                     name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
                     address:
                        name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Evaluation of serum tumor markers in patients with advanced or recurrent breast cancer
      description:Serum CA15-3, CEA, and BCA225 concentrations were determined in 98 patients with advanced or recurrent breast cancer in an attempt to correlate elevation with clinical status. The rate of serum positivity was 68.4% (67/98), 55.1% (54/98), and 43.9% (43/98) for CA15-3, CEA, and BCA225, respectively. After a 4 weeksinterval, a 20% change of tumor marker concentration from the preceding assay correlated significantly with clinical findings. Significant elevation was predictive of new recurrence or tumor regrowth after complete remission, especially in patients with bone metastasis. The 20% change in concentration at 4 weeks was also useful in patients with tumor marker concentrations persistently beneath the cut-off level for positive. Serological evaluation of tumor markers in patients with advanced or recurrent breast cancer should seek to document 20% changes over a 4 week interval.
      datePublished:
      dateModified:
      pageStart:83
      pageEnd:88
      sameAs:https://doi.org/10.1007/BF00666074
      keywords:
         breast cancer
         CA15-3
         CEA
         BCA225
         serological evaluation
         serum markers
         Oncology
      image:
      isPartOf:
         name:Breast Cancer Research and Treatment
         issn:
            1573-7217
            0167-6806
         volumeNumber:33
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Kluwer Academic Publishers
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Hirotaka Iwase
            affiliation:
                  name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
                  address:
                     name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Shunzo Kobayashi
            affiliation:
                  name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
                  address:
                     name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yukashi Itoh
            affiliation:
                  name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
                  address:
                     name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hideki Fukuoka
            affiliation:
                  name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
                  address:
                     name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Tatsuya Kuzushima
            affiliation:
                  name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
                  address:
                     name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hiroji Iwata
            affiliation:
                  name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
                  address:
                     name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Toshinari Yamashita
            affiliation:
                  name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
                  address:
                     name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Akihiro Naitoh
            affiliation:
                  name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
                  address:
                     name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kazuko Itoh
            affiliation:
                  name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
                  address:
                     name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Akira Masaoka
            affiliation:
                  name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
                  address:
                     name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Breast Cancer Research and Treatment
      issn:
         1573-7217
         0167-6806
      volumeNumber:33
Organization:
      name:Kluwer Academic Publishers
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
      address:
         name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
         type:PostalAddress
      name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
      address:
         name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
         type:PostalAddress
      name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
      address:
         name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
         type:PostalAddress
      name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
      address:
         name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
         type:PostalAddress
      name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
      address:
         name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
         type:PostalAddress
      name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
      address:
         name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
         type:PostalAddress
      name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
      address:
         name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
         type:PostalAddress
      name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
      address:
         name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
         type:PostalAddress
      name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
      address:
         name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
         type:PostalAddress
      name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
      address:
         name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Hirotaka Iwase
      affiliation:
            name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
            address:
               name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
               type:PostalAddress
            type:Organization
      name:Shunzo Kobayashi
      affiliation:
            name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
            address:
               name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
               type:PostalAddress
            type:Organization
      name:Yukashi Itoh
      affiliation:
            name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
            address:
               name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
               type:PostalAddress
            type:Organization
      name:Hideki Fukuoka
      affiliation:
            name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
            address:
               name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
               type:PostalAddress
            type:Organization
      name:Tatsuya Kuzushima
      affiliation:
            name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
            address:
               name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
               type:PostalAddress
            type:Organization
      name:Hiroji Iwata
      affiliation:
            name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
            address:
               name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
               type:PostalAddress
            type:Organization
      name:Toshinari Yamashita
      affiliation:
            name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
            address:
               name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
               type:PostalAddress
            type:Organization
      name:Akihiro Naitoh
      affiliation:
            name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
            address:
               name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
               type:PostalAddress
            type:Organization
      name:Kazuko Itoh
      affiliation:
            name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
            address:
               name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
               type:PostalAddress
            type:Organization
      name:Akira Masaoka
      affiliation:
            name:Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment
            address:
               name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
      name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
      name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
      name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
      name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
      name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
      name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
      name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
      name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
      name:Second Department of Surgery, Nagoya City University Medical School, and Cooperative Group for Breast Cancer Treatment, Nagoya, Japan
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(109)

• How much does https://link.springer.com/privacystatement pull in?
• How much does https://link.springer.com/article/10.1007/BF00666074/#main bring in each month?
• How much profit does https://link.springer.com make?
• How much revenue does https://idp.springer.com/auth/personal/springernature?redirect_uri=https://link.springer.com/article/10.1007/BF00666074 produce monthly?
• How much profit does https://link.springer.com/article/10.1007/BF00666074/#eds-c-header-nav make?
• How much does https://link.springer.com/journals/ pull in monthly?
• How much does https://www.springernature.com/gp/authors bring in each month?
• How much does https://link.springernature.com/home/ rake in every month?
• https://link.springer.com/article/10.1007/BF00666074/#eds-c-header-popup-search's total income per month
• What's https://order.springer.com/public/cart's gross income?
• https://link.springer.com/article/10.1007/BF00666074/'s total income per month
• How much profit is https://link.springer.com/article/10.1007/BF00666074/journal/10549 making per month?
• How much revenue does https://link.springer.com/article/10.1007/BF00666074/#citeas produce monthly?
• How much does https://link.springer.com/article/10.1007/BF00666074/journal/10549/aims-and-scope earn?
• What is the monthly revenue of https://submission.springernature.com/new-submission/10549/3?
• What's the profit of https://link.springer.com/article/10.1007/BF00666074/#auth-Hirotaka-Iwase-Aff1?
• What's the profit of https://link.springer.com/article/10.1007/BF00666074/#Aff1?
• How much does https://link.springer.com/article/10.1007/BF00666074/#auth-Shunzo-Kobayashi-Aff1 net monthly?
• What's the monthly money flow for https://link.springer.com/article/10.1007/BF00666074/#auth-Yukashi-Itoh-Aff1?
• https://link.springer.com/article/10.1007/BF00666074/#auth-Hideki-Fukuoka-Aff1 income
• What's the income of https://link.springer.com/article/10.1007/BF00666074/#auth-Tatsuya-Kuzushima-Aff1?
• Find out how much https://link.springer.com/article/10.1007/BF00666074/#auth-Hiroji-Iwata-Aff1 earns monthly
• Learn how profitable https://link.springer.com/article/10.1007/BF00666074/#auth-Toshinari-Yamashita-Aff1 is on a monthly basis
• What's https://link.springer.com/article/10.1007/BF00666074/#auth-Akihiro-Naitoh-Aff1's gross income?
• https://link.springer.com/article/10.1007/BF00666074/#auth-Kazuko-Itoh-Aff1 income
• How much revenue does https://link.springer.com/article/10.1007/BF00666074/#auth-Akira-Masaoka-Aff1 produce monthly?
• How much revenue does https://link.springer.com/article/10.1007/BF00666074/article/10.1007/BF00666074/metrics generate?
• How much cash flow does https://wayf.springernature.com?redirect_uri=https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2FBF00666074 have monthly?
• Explore the financials of https://link.springer.com/product/springer-plus
• Earnings of https://www.springernature.com/gp/librarians/licensing/agc/journals
• https://link.springer.com/article/10.1007/BF00666074/subjects/breast-cancer's financial summary
• How much cash flow does https://link.springer.com/article/10.1007/BF00666074/subjects/cancer-staging have monthly?
• What's the financial gain of https://link.springer.com/article/10.1007/BF00666074/subjects/diagnostic-markers?
• Get to know https://link.springer.com/article/10.1007/BF00666074/subjects/predictive-markers's earnings
• Financial intake of https://link.springer.com/article/10.1007/BF00666074/subjects/prognostic-markers
• What's the income of https://link.springer.com/article/10.1007/BF00666074/subjects/tumour-biomarkers?
• Check the income stats for http://scholar.google.com/scholar_lookup?&title=Evaluation%20of%20effects%20of%20breast%20cancer%20treatments%20by%20serum%20tumor%20marker&journal=Jpn%20J%20Breast%20Cancer&volume=7&pages=356-365&publication_year=1992&author=Iwase%2CH&author=Kobayashi%2CS
• How much cash flow does http://scholar.google.com/scholar_lookup?&title=The%20clinical%20value%20of%20serum%20CA15-3%20assay%20postoperatively%20in%20breast%20cancer%20patients&journal=Jpn%20J%20Surg&volume=19&pages=278-282&publication_year=1989&author=Kobayashi%2CS&author=Iwase%2CH&author=Karamatsu%2CS&author=Matsuo%2CK&author=Masaoka%2CA&author=Miyagawa%2CT have monthly?
• Revenue of http://scholar.google.com/scholar_lookup?&title=Circulating%20CA15-3%20levels%20in%20the%20postsurgical%20follow-up%20of%20breast%20cancer%20patients%20and%20in%20non-malignant%20diseases&journal=Breast%20Cancer%20Research%20and%20Treatment&volume=13&pages=123-133&publication_year=1989&author=Colomer%2CR&author=Ruibal%2CA&author=Genolla%2CJ&author=Rubio%2CD&author=DelCampo%2CJM&author=Bodi%2CR&author=Salvador%2CL
• How much does http://scholar.google.com/scholar_lookup?&title=Circulating%20tumor%20marker%20levels%20in%20advanced%20breast%20carcinoma%20correlate%20with%20the%20extent%20of%20metastatic%20disease&journal=Cancer&volume=64&pages=1674-1681&publication_year=1989&author=Colomer%2CR&author=Ruibal%2CA&author=Salvador%2CL gross monthly?
• See how much http://scholar.google.com/scholar_lookup?&title=The%20tumour%20associated%20antigen%20CA15-3%20in%20primary%20breast%20cancer.%20Evaluation%20of%20667%20cases&journal=Br%20J%20Cancer&volume=63&pages=809-813&publication_year=1991&author=Gion%2CM&author=Mione%2CR&author=Nascimben%2CO&author=Valsecchi%2CM&author=Gatti%2CC&author=Leon%2CA&author=Bruscagnin%2CG makes per month
• How much money does http://scholar.google.com/scholar_lookup?&title=The%20use%20of%20CA15-3%20as%20a%20serum%20tumor%20marker%20in%20breast%20carcinoma&journal=Eur%20J%20Surg%20Oncol&volume=17&pages=16-19&publication_year=1991&author=Duncan%2CJL&author=Price%2CA&author=Rogers%2CK make?
• What are the earnings of http://scholar.google.com/scholar_lookup?&title=CA15-3%20and%20carcinoembryonic%20antigen%20in%20the%20clinical%20evaluation%20of%20breast%20cancer&journal=Clinica%20Chimica%20Acta&volume=200&pages=81-94&publication_year=1991&author=Dnistrian%2CAM&author=Schwartz%2CMK&author=Greenberg%2CEJ&author=Smith%2CCA&author=Schwartz%2CDC?
• What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Immunocytochemical%20distribution%20of%20a%20breast%20carcinoma%20associated%20glycoprotein%20identified%20by%20monoclonal%20antibodies&journal=American%20Journal%20of%20Pathology&volume=130&pages=305-314&publication_year=1988&author=Mesa-Tejada%2CR&author=Palakodety%2CRB&author=Leon%2CJA&author=Khatcherian%2CAO&author=Greaton%2CCJ?
• Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Monoclonal%20antibody%20reactive%20with%20the%20sialyl-sugar%20residue%20of%20a%20high%20molecular%20weight%20glycoprotein%20in%20sera%20of%20cancer%20patient&journal=Jpn%20J%20Cancer%20Res&volume=75&pages=485-488&publication_year=1985&author=Hirohashi%2CS&author=Watanabe%2CM&author=Shimosato%2CY
• What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Tumour%20Marker%20Courses%20to%20assess%20the%20efficacy%20of%20chemotherapy%20or%20hormone%20therapy%20in%20metastasising%20breast%20cancer&journal=Geburtsh%20u%20Frauenheilk&volume=53&pages=24-29&publication_year=1993&author=Mobus%2CV&author=Paula%2CJ&author=Beck%2CT&author=Crombach%2CG&author=Kreienberg%2CR?
• How much does http://scholar.google.com/scholar_lookup?&title=Evaluation%20of%20cancer%20treatment%20by%20serum%20markers&journal=J%20Clin%20Surg&volume=47&pages=6231-628&publication_year=1992&author=Ohkura%2CH&author=Sugano%2CY&author=Shimada%2CY&author=Saitou%2CD&author=Shirao%2CK&author=Okazaki%2CN&author=Okada%2CS&author=Yoshimori%2CM earn?
• What's the revenue for http://scholar.google.com/scholar_lookup?&title=Slope%20analysis%20of%20the%20postoperative%20CEA%20time%20course%20and%20possible%20application%20as%20an%20aid%20in%20diagnosis%20of%20disease%20progression%20in%20gastrointestinal%20cancer&journal=Am%20J%20Surg&volume=136&pages=322-327&publication_year=1978&author=Staab%2CHJ?
• What's the financial outcome of https://citation-needed.springer.com/v2/references/10.1007/BF00666074?format=refman&flavour=references?
• Discover the revenue of https://link.springer.com/article/10.1007/BF00666074/search?sortBy=newestFirst&dc.creator=Hirotaka%20Iwase
• How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Hirotaka%20Iwase bring in?
• Find out how much https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Hirotaka%20Iwase%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earns monthly
• Find out how much https://link.springer.com/article/10.1007/BF00666074/search?sortBy=newestFirst&dc.creator=Shunzo%20Kobayashi earns monthly
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Shunzo%20Kobayashi pull in monthly?
• How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Shunzo%20Kobayashi%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en produce monthly?
• How much revenue does https://link.springer.com/article/10.1007/BF00666074/search?sortBy=newestFirst&dc.creator=Yukashi%20Itoh generate?
• What are the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yukashi%20Itoh?
• How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yukashi%20Itoh%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
• How much does https://link.springer.com/article/10.1007/BF00666074/search?sortBy=newestFirst&dc.creator=Hideki%20Fukuoka earn?
• https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Hideki%20Fukuoka's financial summary
• How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Hideki%20Fukuoka%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
• How much profit does https://link.springer.com/article/10.1007/BF00666074/search?sortBy=newestFirst&dc.creator=Tatsuya%20Kuzushima make?
• Get to know https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Tatsuya%20Kuzushima's earnings
• What's the financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Tatsuya%20Kuzushima%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• What's the monthly money flow for https://link.springer.com/article/10.1007/BF00666074/search?sortBy=newestFirst&dc.creator=Hiroji%20Iwata?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Hiroji%20Iwata pull in?
• How much profit is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Hiroji%20Iwata%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en making per month?
• https://link.springer.com/article/10.1007/BF00666074/search?sortBy=newestFirst&dc.creator=Toshinari%20Yamashita's total income per month
• What's the monthly money flow for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Toshinari%20Yamashita?
• How much income is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Toshinari%20Yamashita%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earning monthly?
• https://link.springer.com/article/10.1007/BF00666074/search?sortBy=newestFirst&dc.creator=Akihiro%20Naitoh's financial summary
• Get to know what's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Akihiro%20Naitoh
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Akihiro%20Naitoh%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en rake in every month?
• How much revenue does https://link.springer.com/article/10.1007/BF00666074/search?sortBy=newestFirst&dc.creator=Kazuko%20Itoh bring in?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kazuko%20Itoh net monthly?
• What's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kazuko%20Itoh%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• Revenue of https://link.springer.com/article/10.1007/BF00666074/search?sortBy=newestFirst&dc.creator=Akira%20Masaoka
• What's the revenue for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Akira%20Masaoka?
• What's the monthly income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Akira%20Masaoka%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• How much revenue does https://s100.copyright.com/AppDispatchServlet?title=Evaluation%20of%20serum%20tumor%20markers%20in%20patients%20with%20advanced%20or%20recurrent%20breast%20cancer&author=Hirotaka%20Iwase%20et%20al&contentID=10.1007%2FBF00666074©right=Kluwer%20Academic%20Publishers&publication=0167-6806&publicationDate=1995-01&publisherName=SpringerNature&orderBeanReset=true produce monthly?
• Get to know https://citation-needed.springer.com/v2/references/10.1007/BF00666074?format=refman&flavour=citation's earnings
• How much revenue does https://link.springer.com/article/10.1007/BF00666074/search?query=breast%20cancer&facet-discipline="Medicine%20%26%20Public%20Health" bring in?
• Revenue of https://link.springer.com/article/10.1007/BF00666074/search?query=CA15-3&facet-discipline="Medicine%20%26%20Public%20Health"
• What's the profit of https://link.springer.com/article/10.1007/BF00666074/search?query=CEA&facet-discipline="Medicine%20%26%20Public%20Health"?
• How much does https://link.springer.com/article/10.1007/BF00666074/search?query=BCA225&facet-discipline="Medicine%20%26%20Public%20Health" pull in?
• What is the earnings of https://link.springer.com/article/10.1007/BF00666074/search?query=serological%20evaluation&facet-discipline="Medicine%20%26%20Public%20Health"?
• How much does https://link.springer.com/article/10.1007/BF00666074/search?query=serum%20markers&facet-discipline="Medicine%20%26%20Public%20Health" bring in each month?
• What's the profit of https://link.springer.com/journals/a/1?
• How much money does https://link.springer.com/books/a/1 generate?
• How profitable is https://link.springer.com/journals?
• Discover the revenue of https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral
• How much does https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research generate monthly?
• Revenue of https://www.springernature.com/gp/products
• What's the monthly money flow for https://www.springernature.com/gp/librarians?
• https://www.springernature.com/gp/societies's total income per month
• How much does https://www.springernature.com/gp/partners gross monthly?
• How much does https://www.springer.com/ pull in monthly?
• Learn about the earnings of https://www.nature.com/
• How much revenue does https://www.biomedcentral.com/ generate?
• Financial intake of https://www.palgrave.com/
• What's the revenue for https://www.apress.com/?
• Profit of https://link.springer.com/brands/discover
• How much income is https://www.springernature.com/gp/legal/ccpa earning monthly?
• How much does https://www.springernature.com/gp/info/accessibility gross monthly?
• Get to know what's the income of https://link.springer.com/termsandconditions
• How much money does https://support.springernature.com/en/support/home make?
• How much does https://link.springer.com/legal-notice bring in each month?
• https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations's total income per month
• How profitable is https://www.springernature.com/?

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Clipboard.js
• Prism.js

Emails and Hosting {✉️}

Mail Servers:

• mx.zoho.eu
• mx2.zoho.eu
• mx3.zoho.eu

Name Servers:

• josh.ns.cloudflare.com
• zita.ns.cloudflare.com

CDN Services {📦}

• Crossref